These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24798643)

  • 1. An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients.
    An YJ; Cho HR; Kim TM; Keam B; Kim JW; Wen H; Park CK; Lee SH; Im SA; Kim JE; Choi SH; Park S
    Int J Cancer; 2015 Jan; 136(1):162-71. PubMed ID: 24798643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis.
    Cho HR; Wen H; Ryu YJ; An YJ; Kim HC; Moon WK; Han MH; Park S; Choi SH
    Cancer Res; 2012 Oct; 72(20):5179-87. PubMed ID: 22926555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Auxiliary Diagnostic Value of Tumor Markers in the Cerebrospinal Fluid and Blood for Leptomeningeal Metastasis from Non-small Cell Lung Cancer].
    Lin Y; Li H; Huang M; Yin Z; Wu J
    Zhongguo Fei Ai Za Zhi; 2020 Jun; 23(6):516-525. PubMed ID: 32517459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare case of pancreatic cancer with leptomeningeal carcinomatosis.
    Yoo IK; Lee HS; Kim CD; Chun HJ; Jeen YT; Keum B; Kim ES; Choi HS; Lee JM; Kim SH; Nam SJ; Hyun JJ
    World J Gastroenterol; 2015 Jan; 21(3):1020-3. PubMed ID: 25624740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid-dissemination of a ovarian clear cell carcinoma: A leptomeningial carcinomatosis with diagnostic challenges.
    Koyuncuer A; Varol E; Serarslan Yağcioğlu B; Bükte Y; Sakcı Z
    Diagn Cytopathol; 2023 Aug; 51(8):E228-E231. PubMed ID: 37071049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases.
    Angus L; Deger T; Jager A; Martens JWM; de Weerd V; van Heuvel I; van den Bent MJ; Sillevis Smitt PAE; Kros JM; Bindels EMJ; Heitzer E; Sleijfer S; Jongen JLM; Wilting SM
    Clin Cancer Res; 2021 May; 27(10):2798-2806. PubMed ID: 33514525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Added Diagnostic Value of Cerebrospinal Fluid Carcinoembryonic Antigen in a Patient with Leptomeningeal Carcinomatosis as the Initial Manifestation of Gastric Cancer.
    Ino R; Sada KE; Miyauchi A; Hashimoto D; Nojima S; Yamanaka S; Kawamura M
    Acta Med Okayama; 2021; 75(5):659-661. PubMed ID: 34703051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptomeningeal carcinomatosis from ethmoid sinus adenocarcinoma.
    Espitalier F; Michel G; Mourrain-Langlois E; Lebouvier T; Bord E; Ferron C; Malard O
    Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Feb; 131(1):49-51. PubMed ID: 23273418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptomeningeal carcinomatosis: prognostic value of clinical, cerebrospinal fluid, and neuroimaging features.
    Palma JA; Fernandez-Torron R; Esteve-Belloch P; Fontes-Villalba A; Hernandez A; Fernandez-Hidalgo O; Gallego Perez-Larraya J; Martinez-Vila E
    Clin Neurol Neurosurg; 2013 Jan; 115(1):19-25. PubMed ID: 22534095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical analysis of leptomeningeal carcinomatosis in 4 cases].
    Bao J; Hu XQ; Jiang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Nov; 28(11):2047-9. PubMed ID: 19033125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer.
    Wang P; Piao Y; Zhang X; Li W; Hao X
    Cancer Biomark; 2013; 13(2):123-30. PubMed ID: 23838141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid cytology and clinical analysis of 34 cases with leptomeningeal carcinomatosis.
    Liu J; Jia H; Yang Y; Dai W; Su X; Zhao G
    J Int Med Res; 2009; 37(6):1913-20. PubMed ID: 20146891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors.
    Lee SJ; Lee JI; Nam DH; Ahn YC; Han JH; Sun JM; Ahn JS; Park K; Ahn MJ
    J Thorac Oncol; 2013 Feb; 8(2):185-91. PubMed ID: 23328548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic Value of Locally Produced Tumor Markers and Blood Brain Barrier
Integrity in Lung Cancer Patients with Leptomeningeal Metastasis].
    Lin Y; Yu T; Li H; Yin Z; Guo A
    Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):567-576. PubMed ID: 34120432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis.
    Torre M; Lee EQ; Chukwueke UN; Nayak L; Cibas ES; Lowe AC
    J Am Soc Cytopathol; 2020; 9(1):45-54. PubMed ID: 31606331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular symptoms secondary to meningeal carcinomatosis in a patient with lung adenocarcinoma: a case report.
    Sabater AL; Sadaba LM; de Nova E
    BMC Ophthalmol; 2012 Dec; 12():65. PubMed ID: 23249254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the cerebrospinal fluid ctDNA detection by next-generation sequencing in the diagnosis of meningeal Carcinomatosis.
    Zhao Y; He JY; Zou YL; Guo XS; Cui JZ; Guo L; Bu H
    BMC Neurol; 2019 Dec; 19(1):331. PubMed ID: 31856745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptomeningeal carcinomatosis: prognostic implications of clinical and cerebrospinal fluid features.
    Bruna J; González L; Miró J; Velasco R; Gil M; Tortosa A;
    Cancer; 2009 Jan; 115(2):381-9. PubMed ID: 19109820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosis.
    Subirá D; Serrano C; Castañón S; Gonzalo R; Illán J; Pardo J; Martínez-García M; Millastre E; Aparisi F; Navarro M; Dómine M; Gil-Bazo I; Pérez Segura P; Gil M; Bruna J
    Neuro Oncol; 2012 Jan; 14(1):43-52. PubMed ID: 21993441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolomic detection of lung cancer biomarkers in sputum.
    Cameron SJ; Lewis KE; Beckmann M; Allison GG; Ghosal R; Lewis PD; Mur LA
    Lung Cancer; 2016 Apr; 94():88-95. PubMed ID: 26973212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.